Labcorp (NYSE:LH) Reports Q2 CY2026 In Line With ExpectationsHealthcare diagnostics company Labcorp Holdings (
NYSE:LH) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.8% year on year to $3.73 billi...
What To Expect From Labcorp’s (LH) Q2 EarningsHealthcare diagnostics company Labcorp Holdings (
NYSE:LH) will be announcing earnings results this Thursday before market hours. Here’s what to look for. Lab...
1 Healthcare Stock with Promising Prospects and 2 Facing HeadwindsPersonal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...
3 Mid-Cap Stocks Walking a Fine LineMany investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco...
3 Reasons LH is Risky and 1 Stock to Buy InsteadLabcorp currently trades at $265.08 per share and has shown little upside over the past six months, posting a middling return of 4.4%. Is now the time to buy...
Q1 Earnings Highlights: Labcorp (NYSE:LH) Vs The Rest Of The Testing & Diagnostics Services StocksQuarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...
2 S&P 500 Stocks for Long-Term Investors and 1 Facing ChallengesThe S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...
3 Cash-Producing Stocks That Concern UsWhile strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
3 Profitable Stocks We Find RiskyWhile profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
3 Healthcare Stocks We Steer Clear OfHealthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recentl...
The 5 Most Interesting Analyst Questions From Labcorp’s Q1 Earnings CallLabcorp’s first quarter was marked by continued growth in both its Diagnostics and Biopharma Laboratory Services businesses, supported by strategic partnersh...
1 of Wall Street’s Favorite Stock with Competitive Advantages and 2 We Turn DownThe stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
LH Q1 Deep Dive: Specialty Testing and Acquisitions Drive Growth Amid Margin ExpansionHealthcare diagnostics company Labcorp Holdings (
NYSE:LH) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 5.8% year on year to $3.54 bill...
Labcorp (NYSE:LH) Beats Q1 CY2026 Sales Expectations, Stock SoarsHealthcare diagnostics company Labcorp Holdings (
NYSE:LH) announced better-than-expected revenue in Q1 CY2026, with sales up 5.8% year on year to $3.54 billi...
What To Expect From Labcorp’s (LH) Q1 EarningsHealthcare diagnostics company Labcorp Holdings (
NYSE:LH) will be reporting results this Thursday before market open. Here’s what you need to know. Labcorp m...
1 S&P 500 Stock to Research Further and 2 We Find RiskyThe S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...
3 Reasons LH is Risky and 1 Stock to Buy InsteadSince October 2025, Labcorp has been in a holding pattern, posting a small loss of 1.9% while floating around $272.50. The stock also fell short of the S&P 5...
2 Profitable Stocks Worth Investigating and 1 That UnderwhelmEven if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
3 Value Stocks We Steer Clear OfThe low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t...
